Buy Day today: Good (67) Broad market participation · no major macro event

Ironwood Pharmaceuticals Inc (IRWD)

Healthcare Drug Manufacturers - Specialty & Generic

4.40 $

+4.5% vs. previous close

Closing price · As of: 3. Aug 2026

Ironwood Pharmaceuticals Inc (IRWD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 435 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet IRWD
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	603	524	471	439	396	390	351	327	343	396	397	435
Current Assets	318	254	233	208	178	179	182	161	192	274	274	332
Cash	175	110	92	122	106	88	89	108	93	140	215	220
Cash & Short-Term Investments	175	110	92	122	106	88	89	108	93	140	215	220
Receivables	119	125	129	72	58	76	82	40	86	120	47	106
Inventory	0.8	0.8	0.0	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	5.9	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	4.1	3.9	3.7	3.5	3.3	3.1	2.9	2.7	2.5	2.2	2.0	1.8
Total Liabilities	950	850	817	769	717	701	652	661	651	660	659	652
Current Liabilities	305	281	276	252	46	49	39	48	233	243	242	236
Short-Term Debt	202	202	203	203	3.2	3.2	3.2	3.2	203	203	203	203
Accounts Payable	3.5	4.7	7.8	6.2	3.2	3.2	2.1	5.8	1.4	1.6	2.9	3.2
Long-Term Debt	598	523	498	473	624	599	584	584	385	385	385	385
Shareholders' Equity	-346	-323	-346	-331	-322	-311	-301	-334	-308	-264	-262	-217
Retained Earnings	-1,713	-1,698	-1,699	-1,703	-1,704	-1,700	-1,698	-1,735	-1,712	-1,671	-1,674	-1,633
Shares Outstanding	155	187	156	158	159	160	160	161	162	178	178	167

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings